1. Home
  2. KSCP vs TIL Comparison

KSCP vs TIL Comparison

Compare KSCP & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$1.63

Market Cap

58.1M

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$7.21

Market Cap

48.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSCP
TIL
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
48.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
KSCP
TIL
Price
$1.63
$7.21
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
$17.00
$125.00
AVG Volume (30 Days)
2.0M
9.5K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
63.54
6.06
EPS
N/A
N/A
Revenue
$11,335,000.00
N/A
Revenue This Year
$218.66
N/A
Revenue Next Year
$54.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.91
N/A
52 Week Low
$1.35
$5.67
52 Week High
$7.62
$33.83

Technical Indicators

Market Signals
Indicator
KSCP
TIL
Relative Strength Index (RSI) 47.18 N/A
Support Level $1.35 N/A
Resistance Level $2.21 N/A
Average True Range (ATR) 0.26 0.00
MACD 0.04 0.00
Stochastic Oscillator 29.79 0.00

Price Performance

Historical Comparison
KSCP
TIL

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: